Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Rinozine is a brand of consumer health products developed by Zakład Farmaceutyczny AMARA, designed to support nasal hygiene, moisturization, and respiratory health. The product line includes Rinozine Ointment, a moisturizing and regenerating topical ointment for the nasal area containing hyaluronic acid, vitamin A, provitamin B5 (panthenol), and hydrolyzed oat protein; Rinozine Aqua, an isotonic nasal spray containing Gulf Stream Sea Water® and glycerol for nasal cleansing and hydration; and Rinozine Zatoki, a dietary supplement in capsule form containing herbal extracts (such as elderberry, mullein, gentian, and African geranium) and zinc to support upper respiratory tract health and immunity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Rinozine.